Document is current
Any future updates will be listed below
-
Authors
Tsuji, Takahiro https://orcid.org/0000-0002-5706-8300
Ozasa, Hiroaki
Aoki, Wataru https://orcid.org/0000-0002-3118-9390
Aburaya, Shunsuke https://orcid.org/0000-0001-6194-9664
Yamamoto Funazo, Tomoko https://orcid.org/0000-0003-2152-2150
Furugaki, Koh
Yoshimura, Yasushi
Yamazoe, Masatoshi https://orcid.org/0000-0003-4088-5432
Ajimizu, Hitomi
Yasuda, Yuto https://orcid.org/0000-0002-5703-4119
Nomizo, Takashi
Yoshida, Hironori
Sakamori, Yuichi
Wake, Hiroaki https://orcid.org/0000-0002-8543-4590
Ueda, Mitsuyoshi
Kim, Young Hak
Hirai, Toyohiro
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (16J03807, 19K23964, 19K08601)
- License Information
-
More Information
Article History
Received: 15 April 2019
Accepted: 25 November 2019
First Online: 3 January 2020
Competing interests
: T.H. is supported by Chugai Pharmaceutical Co., Ltd. Y.H.K. is supported by Chugai Pharmaceutical Co., Ltd., AstraZeneca K.K. (Osaka, Japan), Ono Pharmaceutical Co., Ltd. (Osaka, Japan), Bristol-Myers Squibb K.K. (Tokyo, Japan), Boehringer Ingelheim Japan, Inc. (Tokyo, Japan), and Eli Lilly Japan K.K. (Kobe, Japan) as a honorarium recipient. The remaining authors declare no competing interests.
